
    
      Collected data will include clinical, laboratory and anatomopathological information and will
      be recorded in electronic CRF, at the enrollment and follow-up visits.

      Special attention will be devoted to specific patient categories (with HIV, HBV, HDV and HEV
      coinfections, comorbidities, disease patients who presents signs of liver disease
      progression). Subjects starting an antiviral regimen will be followed according to specific
      guidelines.

      A sub-study on quality of life/adherence to treatment/treatment satisfaction will be also
      conducted on all treated patients of the cohort.
    
  